Performance of a new transdermal nitroglycerin adhesive patch formulation. 1989

D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
Hazleton Laboratories America, Inc., Madison, Wisconsin.

This two-period crossover study in 24 healthy men compared the transdermal absorption of nitroglycerin from a new 20-cm2 nitroglycerin adhesive transdermal patch applied for a single 24-hour period (q24hr) with that from one inch of 2% nitroglycerin ointment applied over a 50-cm2 area every eight hours (q8hr) during a single 24-hour period. The observed differences in pharmacokinetic parameters were expected, based on product design (q24hr vs q8hr) and surface area (20 cm2 vs 50 cm2); however, when corrected for surface area, the mean plasma AUC ratios indicated that the patch delivered about 1.5 times more drug than the ointment. The patch delivery of nitroglycerin was confirmed by patch residual results, which indicated nitroglycerin was released at a rate of 0.75 mg/cm2/24 hrs. The patch exhibited good skin adhesion throughout the 24-hour application period.

UI MeSH Term Description Entries
D008297 Male Males
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
January 1989, Clinical therapeutics,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
January 2016, Drug development and industrial pharmacy,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
June 2016, Drug development and industrial pharmacy,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
October 2022, Pharmaceutics,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
October 2018, International journal of pharmaceutics,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
October 2020, AAPS PharmSciTech,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
July 1986, American heart journal,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
March 1988, The American journal of cardiology,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
December 2012, Journal of pharmaceutical sciences,
D J Riedel, and K A Wick, and R W Hawkinson, and C A Kolars, and J K Crowley, and K E Armstrong, and S F Chang, and L I Harrison, and S R de Dennis
January 1985, Zeitschrift fur Kardiologie,
Copied contents to your clipboard!